Corbus Pharmaceuticals Holdings, Inc. Additional Paid in Capital, Common Stock
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Additional Paid in Capital, Common Stock of $148.89 million as of 2018-12-31, per its 10-K filed 2019-03-12.
Discontinued › Balance Sheet › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2019-03-12
- 2018-12-31: Additional Paid in Capital, Common Stock $148.89M.
- 2018-09-30: Additional Paid in Capital, Common Stock $146.93M.
- 2018-06-30: Additional Paid in Capital, Common Stock $144.94M.
- 2018-03-31: Additional Paid in Capital, Common Stock $142.93M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2018-12-31 | $148.89M 10-K · filed 2019-03-12 |
| 2018-09-30 | $146.93M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $144.94M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $142.93M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $123.48M 10-K · filed 2019-03-12 |
| 2017-09-30 | $86.98M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $85.62M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $84.32M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $42.19M 10-K · filed 2018-03-12 |
| 2016-09-30 | $39.02M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $38.01M 10-Q · filed 2016-08-12 |
| 2016-03-31 | $22.57M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $22.26M 10-K · filed 2017-03-08 |
| 2014-12-31 | $10.29M 10-K · filed 2016-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |